SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from DermTech, Inc. (DMTKQ) (CIK 0001651944) — Aug 15, 2022

DermTech, Inc. (DMTKQ) (CIK 0001651944)
Date: Aug. 15, 2022 · CIK: 0001651944 · Accession: 0001651944-22-000035

AI Filing Summary & Sentiment

File numbers found in text: 333-266650

Date
August 15, 2022
Author
Not clearly detected
Form
CORRESP
Company
DermTech, Inc. (DMTKQ) (CIK 0001651944)

Letter

Document

DERMTECH, INC.

11099 N. Torrey Pines Road, Suite 100

La Jolla, CA 92037

August 15, 2022

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

RE: DermTech, Inc.

Registration Statement on Form S-3

Filed August 8, 2022

File No. 333-266650

Request for Acceleration

Ladies and Gentlemen:

With respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of DermTech, Inc. (the “Company”), that the Securities and Exchange Commission accelerate the effective date of the Registration Statement to Wednesday, August 17, 2022, at 4:05 p.m. Eastern Time, or as soon as practicable thereafter.

The cooperation of the staff in meeting the timetable described above is very much appreciated.

Please call Jeremy Glaser, Melanie Ruthrauff Levy or Jason Miller of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (858) 314-1515, (858) 314-1873 or (858) 314-2140, respectively, with any comments or questions regarding the Registration Statement.

Very truly yours,
DERMTECH, INC.

Show Raw Text
CORRESP
1
filename1.htm

Document

DERMTECH, INC.

11099 N. Torrey Pines Road, Suite 100

La Jolla, CA 92037

August 15, 2022

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

RE:      DermTech, Inc.

    Registration Statement on Form S-3

    Filed August 8, 2022

    File No. 333-266650

    Request for Acceleration

Ladies and Gentlemen:

    With respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of DermTech, Inc. (the “Company”), that the Securities and Exchange Commission accelerate the effective date of the Registration Statement to Wednesday, August 17, 2022, at 4:05 p.m. Eastern Time, or as soon as practicable thereafter.

    The cooperation of the staff in meeting the timetable described above is very much appreciated.

    Please call Jeremy Glaser, Melanie Ruthrauff Levy or Jason Miller of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (858) 314-1515, (858) 314-1873 or (858) 314-2140, respectively, with any comments or questions regarding the Registration Statement.

Very truly yours,

DERMTECH, INC.

/s/ Kevin Sun

Kevin Sun

Chief Financial Officer

cc:    Jeremy Glaser, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

    Melanie Ruthrauff Levy, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

    Jason Miller, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.